2023 Q4 Form 10-Q Financial Statement

#000182912623007558 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $125.0K $50.00K $4.350K
YoY Change 54.46% 1049.43%
Cost Of Revenue -$2.440K $477.00
YoY Change -104.76%
Gross Profit $127.4K $35.00K $3.873K
YoY Change 329.57% 803.69%
Gross Profit Margin 101.95% 70.0% 89.03%
Selling, General & Admin $152.0K $94.77K $67.05K
YoY Change 66.44% 41.34% 28.18%
% of Gross Profit 119.32% 270.77% 1731.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $84.22K
YoY Change -100.0%
% of Gross Profit 0.0% 2174.54%
Operating Expenses $152.0K $94.77K $151.3K
YoY Change -13.39% -37.35% 189.18%
Operating Profit -$24.62K -$59.77K -$147.4K
YoY Change -83.12% -59.45% 181.8%
Interest Expense -$2.320K $3.368K $606.00
YoY Change 455.78%
% of Operating Profit
Other Income/Expense, Net -$14.31K -$3.368K -$606.00
YoY Change 975.94% 455.78%
Pretax Income -$41.26K -$63.14K -$148.0K
YoY Change -97.89% -57.34% 182.93%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$41.26K -$63.14K -$148.0K
YoY Change -97.89% -57.34% 182.93%
Net Earnings / Revenue -33.02% -126.28% -3402.37%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$8.500K
COMMON SHARES
Basic Shares Outstanding 18.33M shares 17.53M shares 17.41M shares
Diluted Shares Outstanding 18.33M shares 16.97M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.07K $43.81K $13.50K
YoY Change 21.32% 224.52%
Cash & Equivalents $45.07K $43.81K $13.50K
Short-Term Investments
Other Short-Term Assets $61.23K $62.18K $2.640K
YoY Change -60.59% 2255.3%
Inventory
Prepaid Expenses $61.23K $62.18K $2.637K
Receivables $4.100K $4.100K
Other Receivables $0.00 $0.00
Total Short-Term Assets $126.1K $124.4K $16.14K
YoY Change -42.85% 670.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $1.025M
YoY Change
Intangibles
YoY Change
Long-Term Investments $800.00 $1.890K
YoY Change
Other Assets $1.090K $1.090K $0.00
YoY Change
Total Long-Term Assets $1.894K $1.894K $1.909M
YoY Change -99.9%
TOTAL ASSETS
Total Short-Term Assets $126.1K $124.4K $16.14K
Total Long-Term Assets $1.894K $1.894K $1.909M
Total Assets $128.0K $126.3K $1.925M
YoY Change -41.99% -93.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $76.45K $38.03K $19.84K
YoY Change 221.96% 91.74% 171.71%
Accrued Expenses $54.32K $15.94K $12.36K
YoY Change -55.12% 29.0%
Deferred Revenue
YoY Change
Short-Term Debt $799.8K $793.6K $421.2K
YoY Change 42.36% 88.39% 352.02%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.031M $987.6K $453.4K
YoY Change 45.85% 117.81% 351.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.031M $987.6K $453.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.031M $987.6K $453.4K
YoY Change 45.85% 117.81% 351.26%
SHAREHOLDERS EQUITY
Retained Earnings -$104.7M -$104.7M -$101.9M
YoY Change 0.84% 2.74%
Common Stock $18.33K $18.33K $17.41K
YoY Change 5.26% 5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$902.6K -$861.3K $1.471M
YoY Change
Total Liabilities & Shareholders Equity $128.0K $126.3K $1.925M
YoY Change -41.99% -93.44%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$41.26K -$63.14K -$148.0K
YoY Change -97.89% -57.34% 182.93%
Depreciation, Depletion And Amortization $0.00 $84.22K
YoY Change -100.0%
Cash From Operating Activities -$4.990K -$92.76K -$61.79K
YoY Change -96.2% 50.12% 36.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$14.31K
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00 -$14.31K
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.240K 23.38K 61.97K
YoY Change -95.56% -62.27% 36.65%
NET CHANGE
Cash From Operating Activities -4.990K -92.76K -61.79K
Cash From Investing Activities 0.000 0.000 -14.31K
Cash From Financing Activities 6.240K 23.38K 61.97K
Net Change In Cash 1.250K -69.38K -14.13K
YoY Change -94.71% 391.01%
FREE CASH FLOW
Cash From Operating Activities -$4.990K -$92.76K -$61.79K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001558740
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
usd
CY2022Q4 us-gaap Investments
Investments
usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2022Q3 wnlv Cost Of Sales Related Party
CostOfSalesRelatedParty
usd
wnlv Cost Of Sales Related Party
CostOfSalesRelatedParty
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q3 us-gaap Other Income
OtherIncome
usd
CY2022Q3 us-gaap Other Income
OtherIncome
usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56204
dei Entity Registrant Name
EntityRegistrantName
WINVEST GROUP LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2052033
dei Entity Address Address Line1
EntityAddressAddressLine1
50 West Liberty Street
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 880
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89501
dei City Area Code
CityAreaCode
(775)
dei Local Phone Number
LocalPhoneNumber
996-0288
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18326075 shares
CY2023Q3 us-gaap Cash
Cash
43811 usd
CY2022Q4 us-gaap Cash
Cash
37148 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4100 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28147 usd
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
14310 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
62181 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
155354 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
124402 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
220648 usd
CY2023Q3 us-gaap Investments
Investments
800 usd
CY2023Q3 us-gaap Security Deposit
SecurityDeposit
1094 usd
CY2023Q3 us-gaap Assets
Assets
126296 usd
CY2022Q4 us-gaap Assets
Assets
220648 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
38031 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23746 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15938 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21040 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
40071 usd
CY2023Q3 wnlv Project Advances
ProjectAdvances
100000 usd
CY2022Q4 wnlv Project Advances
ProjectAdvances
100000 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
41937 usd
CY2023Q3 wnlv Notes Payablerelated Parties Current
NotesPayablerelatedPartiesCurrent
751649 usd
CY2022Q4 wnlv Notes Payablerelated Parties Current
NotesPayablerelatedPartiesCurrent
561830 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
987626 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
706615 usd
CY2023Q3 us-gaap Liabilities
Liabilities
987626 usd
CY2022Q4 us-gaap Liabilities
Liabilities
706615 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
-0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
-0 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
227839 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
227839 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18326075 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18326075 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17411217 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17411217 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
18326 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17411 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103571797 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103113871 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104679292 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-103845089 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-861330 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-485968 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126296 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220648 usd
CY2023Q3 us-gaap Revenues
Revenues
50000 usd
CY2022Q3 us-gaap Revenues
Revenues
4350 usd
us-gaap Revenues
Revenues
214978 usd
us-gaap Revenues
Revenues
8350 usd
CY2023Q3 wnlv Cost Of Sales Related Party
CostOfSalesRelatedParty
15000 usd
wnlv Cost Of Sales Related Party
CostOfSalesRelatedParty
15000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
477 usd
us-gaap Cost Of Revenue
CostOfRevenue
108307 usd
us-gaap Cost Of Revenue
CostOfRevenue
477 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
35000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
3873 usd
us-gaap Gross Profit
GrossProfit
91671 usd
us-gaap Gross Profit
GrossProfit
7873 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54782 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67054 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
827706 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
275020 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
39989 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
84217 usd
us-gaap Professional Fees
ProfessionalFees
103014 usd
us-gaap Professional Fees
ProfessionalFees
126307 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
94771 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
151270 usd
us-gaap Operating Expenses
OperatingExpenses
930720 usd
us-gaap Operating Expenses
OperatingExpenses
401327 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-59771 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-147397 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-839049 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-393454 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
3368 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
606 usd
us-gaap Interest Expense
InterestExpense
9467 usd
us-gaap Interest Expense
InterestExpense
797 usd
us-gaap Other Income
OtherIncome
14313 usd
us-gaap Other Income
OtherIncome
129 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3368 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-606 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4846 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-668 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-63139 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-148003 usd
us-gaap Net Income Loss
NetIncomeLoss
-834203 usd
us-gaap Net Income Loss
NetIncomeLoss
-394122 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18326075 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18326075 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16966000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16966000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17776243 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17776243 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16966000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16966000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-114522 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-150017 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-264539 usd
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1980000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-96102 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1619358 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-148003 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1471355 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-485968 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
458040 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-654791 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-682719 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-116273 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-798992 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
800 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-63139 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-861330 usd
us-gaap Net Income Loss
NetIncomeLoss
-834203 usd
us-gaap Net Income Loss
NetIncomeLoss
-394122 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
126307 usd
us-gaap Share Based Compensation
ShareBasedCompensation
458040 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24047 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
14310 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-93172 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1094 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14284 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1048 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5101 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12355 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40071 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-225094 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-254412 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-15490 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15490 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
41937 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
113736 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
303556 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
252425 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231757 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
252425 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6663 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13502 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37148 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43811 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13502 usd
CY2012Q1 wnlv Issuance Of Common Stock For Donated Service
IssuanceOfCommonStockForDonatedService
98984744 shares
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 250
us-gaap Fiscal Period
FiscalPeriod
<p id="xdx_849_eus-gaap--FiscalPeriod_z2eEHAlYEKv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86E_zYiH1QsQcFC2">Change in Fiscal Year-End</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 14, 2021, the Company’s Board of Directors approved the change in the Company’s fiscal year end from May 31 to December 31.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 250
CY2023Q3 wnlv Working Capital Deficit
WorkingCapitalDeficit
863224 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104679292 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_z8Z9qTP2FPXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_zm0eWE7AaLDi">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities at the date of the condensed consolidated financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these condensed financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<p id="xdx_848_eus-gaap--RevenueRecognitionSalesOfServices_zegNktPyRUHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zptpMXVtp6Si">Production – Cost of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cost of revenue is comprised of labor expense calculated based on an hourly labor rate provided by consultants and employees to produce revenue, as well as portion of office expense which is allocated to each project. Additionally, the cost of revenue includes direct expenses related to the revenues provided, such as managing the client’s Amazon sales channel through the creation of promotional advertisements to increase sales, translation of content into different languages, coordination of projects with different work teams to maximize client benefits, production crew for celebrity endorsements and video shooting, and salaries and wages of employees involved in creating and delivering these services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1810116 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
43811 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
37148 usd
CY2023Q3 wnlv Project Advances
ProjectAdvances
100000 usd
CY2022Q4 wnlv Project Advances
ProjectAdvances
100000 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1810116 usd
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
0 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
0 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
41937 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q3 wnlv Notes Payable Related Parties
NotesPayableRelatedParties
751093 usd
CY2022Q4 wnlv Notes Payable Related Parties
NotesPayableRelatedParties
561830 usd
CY2023Q3 wnlv Project Advances
ProjectAdvances
100000 usd
CY2022Q4 wnlv Project Advances
ProjectAdvances
100000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18326075 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18326075 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17411217 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17411217 shares
us-gaap Share Based Compensation
ShareBasedCompensation
458040 usd
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
855000 shares
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
855000 shares
us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3420 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Each share of preferred stock is convertible to 50 shares of common stock.

Files In Submission

Name View Source Status
0001829126-23-007558-index-headers.html Edgar Link pending
0001829126-23-007558-index.html Edgar Link pending
0001829126-23-007558.txt Edgar Link pending
0001829126-23-007558-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
winvestgroup_10q.htm Edgar Link pending
winvestgroup_ex31-1.htm Edgar Link pending
winvestgroup_ex31-2.htm Edgar Link pending
winvestgroup_ex32-1.htm Edgar Link pending
winvestgroup_ex32-2.htm Edgar Link pending
wnlv-20230930.xsd Edgar Link pending
wnlv-20230930_cal.xml Edgar Link unprocessable
wnlv-20230930_def.xml Edgar Link unprocessable
wnlv-20230930_lab.xml Edgar Link unprocessable
wnlv-20230930_pre.xml Edgar Link unprocessable
winvestgroup_10q_htm.xml Edgar Link completed